These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 25511904)

  • 1. Geographic miss of lung tumours due to respiratory motion: a comparison of 3D vs 4D PET/CT defined target volumes.
    Callahan J; Kron T; Siva S; Simoens N; Edgar A; Everitt S; Schneider ME; Hicks RJ
    Radiat Oncol; 2014 Dec; 9():291. PubMed ID: 25511904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [4D-CT-based plan target volume (PTV) definition compared with conventional PTV definition using general margin in radiotherapy for lung cancer].
    Ju X; Li M; Zhou Z; Zhang K; Han W; Fu G; Cao Y; Wang L
    Zhonghua Zhong Liu Za Zhi; 2014 Jan; 36(1):34-8. PubMed ID: 24685084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
    Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
    Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric Consequences of 3D Versus 4D PET/CT for Target Delineation of Lung Stereotactic Radiotherapy.
    Siva S; Chesson B; Callahan JW; Hardcastle N; Crawford L; Antippa P; Wright G; MacManus MP; Hicks RJ; Kron T; Ball DL
    J Thorac Oncol; 2015 Jul; 10(7):1112-5. PubMed ID: 26134229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume.
    Admiraal MA; Schuring D; Hurkmans CW
    Radiother Oncol; 2008 Jan; 86(1):55-60. PubMed ID: 18082905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4D-Listmode-PET-CT and 4D-CT for optimizing PTV margins in gastric lymphoma : Determination of intra- and interfractional gastric motion.
    Reinartz G; Haverkamp U; Wullenkord R; Lehrich P; Kriz J; Büther F; Schäfers K; Schäfers M; Eich HT
    Strahlenther Onkol; 2016 May; 192(5):322-32. PubMed ID: 26902523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel four-dimensional radiotherapy planning strategy from a tumor-tracking beam's eye view.
    Li G; Cohen P; Xie H; Low D; Li D; Rimner A
    Phys Med Biol; 2012 Nov; 57(22):7579-98. PubMed ID: 23103415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of FDG-PET on computed tomography-based radiotherapy planning for locally recurrent nasopharyngeal carcinoma.
    Zheng XK; Chen LH; Wang QS; Wu HB; Wang HM; Chen YQ; Yan WP; Li QS; Xu YK
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1381-8. PubMed ID: 17869450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can PET provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitations of CT and the promise of PET.
    Caldwell CB; Mah K; Skinner M; Danjoux CE
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1381-93. PubMed ID: 12654451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the planning target volume based on three-dimensional CT and four-dimensional CT images of non-small-cell lung cancer.
    Li FX; Li JB; Zhang YJ; Liu TH; Tian SY; Xu M; Shang DP; Ma CS
    Radiother Oncol; 2011 May; 99(2):176-80. PubMed ID: 21549440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four-dimensional radiotherapy planning for DMLC-based respiratory motion tracking.
    Keall PJ; Joshi S; Vedam SS; Siebers JV; Kini VR; Mohan R
    Med Phys; 2005 Apr; 32(4):942-51. PubMed ID: 15895577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer.
    Leong T; Everitt C; Yuen K; Condron S; Hui A; Ngan SY; Pitman A; Lau EW; MacManus M; Binns D; Ackerly T; Hicks RJ
    Radiother Oncol; 2006 Mar; 78(3):254-61. PubMed ID: 16545881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Motion Assessment With 4-Dimensional Computed Tomographic Imaging for Non-Small Cell Lung Cancer Radiotherapy Improve Target Volume Coverage?
    Ahmed N; Venkataraman S; Johnson K; Sutherland K; Loewen SK
    Clin Med Insights Oncol; 2017; 11():1179554917698461. PubMed ID: 28469512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion of respiration-correlated PET and CT scans: correlated lung tumour motion in anatomical and functional scans.
    Wolthaus JW; van Herk M; Muller SH; Belderbos JS; Lebesque JV; de Bois JA; Rossi MM; Damen EM
    Phys Med Biol; 2005 Apr; 50(7):1569-83. PubMed ID: 15798344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of respiration induced intra- and inter-fractional tumour motion using a standard Cone Beam CT.
    Gottlieb KL; Hansen CR; Hansen O; Westberg J; Brink C
    Acta Oncol; 2010 Oct; 49(7):1192-8. PubMed ID: 20831512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in target definition using three different methods to include respiratory motion in radiotherapy of lung cancer.
    Sloth Møller D; Knap MM; Nyeng TB; Khalil AA; Holt MI; Kandi M; Hoffmann L
    Acta Oncol; 2017 Nov; 56(11):1604-1609. PubMed ID: 28885090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of 4D treatment planning target volumes.
    Rietzel E; Liu AK; Doppke KP; Wolfgang JA; Chen AB; Chen GT; Choi NC
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):287-95. PubMed ID: 16904528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Internal target volume definition using four-dimensional CT and dosimetric evaluation for hepatocellular carcinoma].
    Xi M; Liu MZ; Deng XW; Liu H; Huang XY; Zhang L; Li QQ; Hu YH; Cai L; Cui NJ
    Ai Zheng; 2007 Jan; 26(1):1-8. PubMed ID: 17222359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ITV versus mid-ventilation for treatment planning in lung SBRT: a comparison of target coverage and PTV adequacy by using in-treatment 4D cone beam CT.
    Bellec J; Arab-Ceschia F; Castelli J; Lafond C; Chajon E
    Radiat Oncol; 2020 Mar; 15(1):54. PubMed ID: 32127010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor control probability and the utility of 4D vs 3D dose calculations for stereotactic body radiotherapy for lung cancer.
    Valdes G; Robinson C; Lee P; Morel D; Low D; Iwamoto KS; Lamb JM
    Med Dosim; 2015; 40(1):64-9. PubMed ID: 25542785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.